Close Menu

NEW YORK (360Dx) — Digital pathology firm PathAI announced today that it has closed a $60 million Series B financing round.

The round was led by new investor General Atlantic with participation from existing investors including General Catalyst. In conjunction with the round, General Atlantic Managing Director Michelle Dipp will join PathAI's board.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.